Literature DB >> 10760068

Mineralocorticoid selectivity: molecular and cellular aspects.

N Farman1, B Bocchi.   

Abstract

Aldosterone acts in mineralocorticoid-sensitive cells by binding to the mineralocorticoid receptor (MR). Because the MR displays similar affinity for aldosterone and glucocorticoid hormones and because these latter hormones are 100- to 1000-fold more abundant than aldosterone in the plasma, mechanisms are required to avoid permanent illicit occupancy of MR by glucocorticoid hormones. The main mechanism of mineralocorticoid selectivity is enzymatic: the 11beta hydroxysteroid dehydrogenase (HSD2) metabolizes glucocorticoid hormones into derivatives with a low affinity for MR. The cell biology and regulation of HSD2 are reviewed in this article, as well as its implications in human hypertension. Other factors play a role in mineralocorticoid selectivity: the MR itself, the possibility to form homodimers (MR-MR), or heterodimers (with the glucocorticoid receptor). All of these cellular events participate to successive dynamic equilibriums, which allow fine tuning of transcriptional regulation of target genes, depending on the target tissue and the hormonal status.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760068     DOI: 10.1046/j.1523-1755.2000.00976.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

1.  MDM2: a novel mineralocorticoid-responsive gene involved in aldosterone-induced human vascular structural remodeling.

Authors:  Yasuhiro Nakamura; Saya Suzuki; Takashi Suzuki; Katsuhiko Ono; Ikumi Miura; Fumitoshi Satoh; Takuya Moriya; Haruo Saito; Shogo Yamada; Sadayoshi Ito; Hironobu Sasano
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 2.  Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease.

Authors:  Nicholas C Bene; Pilar Alcaide; Henry H Wortis; Iris Z Jaffe
Journal:  Steroids       Date:  2014-04-21       Impact factor: 2.668

Review 3.  Nuclear receptors in neural stem/progenitor cell homeostasis.

Authors:  Dimitrios Gkikas; Matina Tsampoula; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2017-06-21       Impact factor: 9.261

4.  Aldosterone stimulates surface expression of NHE3 in renal proximal brush borders.

Authors:  Alexander W Krug; Friderun Papavassiliou; Ulrich Hopfer; Karl J Ullrich; Michael Gekle
Journal:  Pflugers Arch       Date:  2003-04-09       Impact factor: 3.657

5.  Effects of aldosterone and related steroids on LPS-induced increased expression of inducible NOS in rat aortic smooth muscle cells.

Authors:  V Godfrey; A L Martin; A D Struthers; G A Lyles
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

6.  Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization.

Authors:  Richard Bafford; Xin Xin Sui; Min Park; Takuya Miyahara; Brenna G Newfell; Iris Z Jaffe; Jose R Romero; Gail K Adler; Gordon H Williams; Raouf A Khalil; Michael S Conte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-02       Impact factor: 4.733

7.  Design of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) Trial.

Authors:  Sanjay Rajagopalan; M Amer Alaiti; Kylene Broadwater; Aditya Goud; Juan Gaztanaga; Kim Connelly; Anas Fares; Shayan Shirazian; Catherine Kreatsoulas; Michael Farkouh; Mirela Dobre; Jeffrey C Fink; Matthew R Weir
Journal:  Clin Cardiol       Date:  2017-05-26       Impact factor: 2.882

8.  Role of glucocorticoids in the maturation of the rat renal Na+/H+ antiporter (NHE3).

Authors:  N Gupta; S R Tarif; M Seikaly; M Baum
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

9.  Spironolactone prevents dietary-induced metabolic syndrome by inhibiting PI3-K/Akt and p38MAPK signaling pathways.

Authors:  H D Long; Y E Lin; M J Liu; L Y Liang; Z H Zeng
Journal:  J Endocrinol Invest       Date:  2013-04-23       Impact factor: 4.256

10.  Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation.

Authors:  Pei De-An; Li Li; Xu Zhi-Yun; Huang Jin-Yu; Xu Zheng-Ming; Wang Min; Yao Qiang; Huang Shi-Eng
Journal:  Clin Cardiol       Date:  2010-01       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.